During this activity, attendees will learn:
- IgA is the predominant antibody in mucosal secretions
- The benefits of adding an adjuvant or adjuvant combinations to a vaccine formulation
- Differences in vaccine-induced immune responses induced by intramuscular immunization when compared to intranasal immunization
- The benefit of vaccine-induced mucosal IgA for protection against respiratory pathogens
Add to calendar:
Session date:
08/13/2021 - 12:00pm to 1:00pm EDT
Room Number:
Zoom Meeting
Speaker Name:
Herman Staats, PhD